ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II trial of alternate schedule of chemotherapy as front-line treatment in metastatic non-small cell lung cancer (NSCLC): A single-centre experience
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.19120
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 19120-19120
Author(s):
R. López Castro
◽
G. Martín
◽
R. Seijas
◽
L. Bellido
◽
E. del Barco
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Single Centre
◽
Single Centre Experience
◽
Alternate Schedule
Download Full-text
Related Documents
Cited By
References
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial
Annals of Oncology
◽
10.1023/a:1008336931378
◽
2000
◽
Vol 11
(4)
◽
pp. 435-440
◽
Cited By ~ 115
Author(s):
C. Manegold
◽
U. Gatzemeier
◽
J. von Pawel
◽
R. Pirker
◽
R. Malayeri
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Multicenter Phase
◽
Pemetrexed Disodium
Download Full-text
Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial
Lung Cancer
◽
10.1016/s0169-5002(98)90063-0
◽
1998
◽
Vol 21
◽
pp. S33
◽
Cited By ~ 1
Author(s):
V Georgoulias
◽
Ch Kourousis
◽
N Androulakis
◽
S Kakolyris
◽
MA Dimopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000284313.78584.ac
◽
2007
◽
Vol 2
(8)
◽
pp. S824
Author(s):
Andriani G. Charpidou
◽
Nikolaos Katirtzoglou
◽
Ioannis Gkiozos
◽
Eleni Karapanagiotou
◽
Anna Rigopoulou
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer
Clinical Lung Cancer
◽
10.1016/j.cllc.2011.08.004
◽
2012
◽
Vol 13
(2)
◽
pp. 129-135
◽
Cited By ~ 5
Author(s):
Athanasios G. Pallis
◽
Alexandra Voutsina
◽
Nikolaos Kentepozidis
◽
Stylianos Giassas
◽
Pavlos Papakotoulas
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
Download Full-text
P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.01.875
◽
2021
◽
Vol 16
(3)
◽
pp. S501
Author(s):
P. Deng
◽
H. Yang
◽
C. Chen
◽
C. Hu
◽
L. Cao
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Extensive Stage
Download Full-text
P48.09 Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.01.879
◽
2021
◽
Vol 16
(3)
◽
pp. S503
Author(s):
B. Han
◽
W. Zhang
◽
B. Zhang
◽
Y. Chen
◽
Y. Zhang
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
First Line
◽
Extensive Stage
◽
First Line Treatment
Download Full-text
9095 POSTER Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer
European Journal of Cancer
◽
10.1016/s0959-8049(11)72407-8
◽
2011
◽
Vol 47
◽
pp. S621
Author(s):
J. Baek
◽
J. Ahn
◽
Y. Jegal
◽
C. Park
◽
Y. Lee
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
First Line
◽
Prospective Phase
◽
First Line Treatment
Download Full-text
Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
Anticancer Research
◽
10.21873/anticanres.12661
◽
2018
◽
Vol 38
(6)
◽
pp. 3779-3784
◽
Cited By ~ 1
Author(s):
HIROAKI TAKEOKA
◽
KAZUHIKO YAMADA
◽
YOSHIKO NAITO
◽
NORIKAZU MATSUO
◽
HIDENOBU ISHII
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
First Line
◽
First Line Treatment
Download Full-text
Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment
Lung Cancer
◽
10.1016/j.lungcan.2019.06.025
◽
2019
◽
Vol 135
◽
pp. 33-39
◽
Cited By ~ 5
Author(s):
Ippokratis Messaritakis
◽
Michalis Nikolaou
◽
Fillipos Koinis
◽
Eleni Politaki
◽
Anastasios Koutsopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Tumor Cells
◽
Circulating Tumor Cells
◽
Clinical Relevance
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
Download Full-text
A Novel Phase Ii Trial of Ipilimumab, Carboplatin and Etoposide (Ice) for the First Line Treatment of Extensive Stage Small Cell Lung Cancer (Sclc)
Annals of Oncology
◽
10.1093/annonc/mdu355.15
◽
2014
◽
Vol 25
◽
pp. iv516
Author(s):
C. Ottensmeier
◽
I. Galea
◽
N. Cross
◽
T. Maishman
◽
D. Hamid
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
First Line
◽
Extensive Stage
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close